Table 2.
Demographic characteristics, thyroid stimulating hormone and thyroid hormones levels in male and female MDR-TB patients without HIV infection and MDR-TB patients with HIV infection
| Male (n = 76) | Female (n = 39) | P-value | |
| Age (years) | 37.30 ± 11.04 | 30.54 ± 8.64 | 0.001* |
| Height (m) | 1.65 ± 0.28 | 1.61 ± 0.10 | 0.395 |
| Body weight (kg) | 51.62± 13.03 | 43.33 ± 9.37 | 0.001* |
| BMI (kg/m2) | 17.44 ± 5.12 | 16.65 ± 3.26 | 0.385 |
| TSH (IU/ml) | 1.80 (1.20 – 3.40) | 1.90 (1.20 – 3.50) | 0.908 |
| fT4 (nmol/L) | 87.00 (67.10 – 101.50) | 93.00 (70.00 – 112.00) | 0.116 |
| fT3 (ng/ml) | 1.00 (0.75 – 1.75) | 1.20 (0.73 – 1.50) | 0.895 |
*
Significant at P<0.05, BMI= body mass index, TSH=thyroid stimulating hormone, fT4 =free thyroxine, fT3 = free triiodothyronine, values are presented in mean ± standard deviation or median (interquartile range)